Neostigmine Methylsulfate Injection, Solution
Product Images NDC 76045-383

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 76045-383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Neo0i 0002 01)

Chemical structure of Neostigmine Methylsulfate. The diagram shows the aromatic ring with attached functional groups, including a quaternary ammonium group, methylsulfate counterion, and carbamate moiety characteristic of Neostigmine Methylsulfate.*

FDA Label Image

Figure 1 (Neo0i 0002 02)

An instructional diagram showing an outer package and a labeled syringe of Neostigmine Methylsulfate injection. The syringe components identified include the plunger rod, syringe barrel, syringe tip cap, luer lock collar, and a label marked 'Do not remove.' The image details assembly parts for intravenous injection use.*

FDA Label Image

Figure 2 (Neo0i 0002 03)

An instructional line drawing showing hands removing a protective cover from a syringe containing Neostigmine Methylsulfate injection, solution. The image demonstrates preparation for intravenous administration of the 1 mg/mL solution.*

FDA Label Image

Figure 3 (Neo0i 0002 04)

An instructional illustration showing a hand holding a vial while another hand is removing the vial's cap by pulling it off. A directional arrow indicates the motion of removing the cap. This image depicts a step in preparing an injection vial for use.*

FDA Label Image

Fresenius Kabi Logo (Neo0i 0002 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Neostigmine Methylsulfate Injection, USP showing 3 mg per 3 mL (1 mg per mL) solution in a 3 mL single-dose prefilled syringe. The label includes volume markings from 0.5 mL to 3 mL and states for IV use only. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Neostigmine Methylsulfate Injection, USP 3 mg per 3 mL (equivalent to 1 mg per mL) in a 3 mL single-dose prefilled syringe for intravenous use. The label includes storage instructions, dosage information, and is labeled by Fresenius Kabi USA, LLC. The packaging also shows an expiration date placeholder and lot number.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Neostigmine 3 mg per 3 mL (1 mg per mL) Methylsulfate Injection, USP, intravenous solution packaged in 10 x 3 mL single-dose prefilled syringes. Label shows storage instructions, preservative details, barcodes, and manufacturer Fresenius Kabi USA, LLC.*

FDA Label Image

Neo0i 0002 09

Label for Neostigmine Methylsulfate Injection, USP showing 3 mg per 3 mL (1 mg per mL) in a single-dose prefilled syringe. Markings indicate volume from 0.5 mL to 3 mL. The label includes a barcode, an RFID symbol, and the labeler name Fresenius Kabi.*

FDA Label Image

Neo0i 0002 10

Neostigmine Methylsulfate Injection, USP 3 mg per 3 mL (1 mg per mL) in a 3 mL single-dose prefilled syringe. The label indicates intravenous use only, prescription drug status, and includes storage instructions, lot number, expiration date placeholder, and barcodes. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Neo0i 0002 11

Neostigmine Methylsulfate Injection, USP 3 mg per 3 mL (1 mg per mL) carton label for intravenous use only. The packaging contains 10 single-dose prefilled syringes of 3 mL each. Labeler is Fresenius Kabi USA, LLC. Includes storage instructions and caution not to place syringe on a sterile field.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.